Table 1.
Any reported VP∗,† in last 3 months | No reported VP in last 3 months | Overall | ||||
---|---|---|---|---|---|---|
Participant characteristics | n = 1435 | % | n = 749 | % | n = 2185‡ | % |
| ||||||
Contraceptive group | ||||||
COC* | 511 | 36 | 306 | 41 | 817 | 37 |
DMPA* | 522 | 36 | 236 | 32 | 758 | 35 |
Nonhormonal | 402 | 28 | 207 | 28 | 610 | 28 |
Cohabitating with primary partner | ||||||
Yes | 1328 | 93 | 697 | 93 | 2026 | 93 |
No | 107 | 7 | 52 | 7 | 159 | 7 |
Ever engaged in commercial sex | ||||||
Yes | 15 | 1 | 6 | 1 | 21 | 1 |
No | 1420 | 99 | 743 | 99 | 2164 | 99 |
| ||||||
Median | IQR | Median | IQR | Median | IQR | |
| ||||||
Age (years) | 26 | 23–29 | 25 | 22–28 | 26 | 22–29 |
Schooling (years) | 11 | 9–11 | 11 | 9-11 | 11 | 9–11 |
Nights partner away in last month | 0 | 0–2 | 0 | 0–2 | 0 | 0–2 |
Sex acts with primary partner per month | 14 | 8–24 | 14 | 8–20 | 14 | 8–22 |
Partners in last 3 months | 1 | 1-1 | 1 | 1-1 | 1 | 1-1 |
*COC = combined oral contraceptives; DMPA = depot medroxyprogesterone acetate; IQR = interquartile range; VP = vaginal practices.
†Includes reports of internal vaginal cleansing, drying, or tightening.
‡One participant was missing vaginal practices data at baseline, thus one additional person is included in the “overall” column.